PRESS STATEMENTS

08.14.2019

Pfizer Inc. Issues A Voluntary Nationwide Recall For 2 Lots of RELPAX® (eletriptan hydrobromide) 40 mg Tablets Due to Potential Microbiological Contamination of Non-Sterile Products

07.26.2019

Pfizer Statement on Update to XELJANZ® (tofacitinib) Prescribing Information in the United States

05.17.2019

Pfizer confirms initiation of EU review of Tofacitinib with interim recommendations

04.26.2019

Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall of One Lot of ThermaCare® Back Pain Therapy HeatWraps, up to 16HR pain relief, Due To Out of Specification Results for High Cell Temperature

03.18.2019

Hospira, Inc. Issues A Voluntary Nationwide Recall of 8.4% Sodium Bicarbonate Injection, USP Due To The Presence of Particulate Matter.

02.19.2019

Pfizer Announces Modification To Ongoing Tofacitinib FDA Post-Marketing Requirement Study In Patients With Rheumatoid Arthritis

11.26.2018

Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall Of Six Lots Of ThermaCare® HeatWraps Due To Leaking Wraps with the Potential For Skin Injuries

11.16.2018

Pfizer Provides Transparency On Drug Prices In The U.S. 90 Percent Of Company’s Prices Will Remain Unchanged

11.11.2018

Real-World Evidence on Patients Aged 80 and Older Presented From ARISTOPHANES, the Largest Real-World Data Study Evaluating Oral Anticoagulants Among Patients with Non-Valvular Atrial Fibrillation

11.09.2018

Data From Phase 2 PALLET Study of IBRANCE® (palbociclib)in Early Breast Cancer to be Presented at San Antonio Breast Cancer Symposium

10.18.2018

Pfizer Announces Initiation of Phase 3 Trial of Tofacitinib in Patients with Ankylosing Spondylitis

09.12.2018

Terry Bradshaw and Pfizer Encourage Boomers to Understand Their Risk for Pneumococcal Pneumonia and Take Action to Help Prevent It

08.27.2018

Pfizer, Inc. Issues A Voluntary Nationwide Recall Of One Lot Of Children’s Advil® Suspension Bubble Gum Flavored 4 FL OZ Bottle

08.22.2018

Exact Sciences and Pfizer Enter into U.S. Promotion Agreement for Cologuard®

08.21.2018

Important Update on EpiPen® (epinephrine injection, USP) 0.3 mg Auto-Injectors

08.20.2018

Bristol-Myers Squibb-Pfizer Alliance ACROPOLIS™ Real-World Data Program Grows to Sample Size of Nearly One Million Lives Worldwide

08.08.2018

Important Notice Regarding EpiPen Auto-Injector U.S. Supply

07.25.2018

Pfizer Clarifies Incorrect Media Reports Regarding Amsterdam UMC Clinical Trial

07.23.2018

Dr. Seng Hing Cheng appointed Chief Scientific Officer of Pfizer Rare Disease Research Unit

07.10.2018

Pfizer announces it will defer company’s price increases